JUN and rheumatoid arthritis: Data showed that melittin can treat RA through a multi-target and multi-pathway mechanism, and melittin’s therapeutic effect was believed to involve important hub targets such as STAT3, AKT1, TNF, JUN, IL1B, MAPK, and VEGFA.